Motor System
Motor System
What Do You Need to Know?
- Motor hierarchy — cortex → basal ganglia/cerebellum → brainstem → spinal cord → peripheral nerve → NMJ → muscle
- Corticospinal tract anatomy — origin, internal capsule somatotopy, pyramidal decussation, lateral vs. anterior CST
- UMN vs. LMN distinction — tone, reflexes, Babinski, atrophy, fasciculations — the single most tested motor concept
- Motor unit physiology — alpha vs. gamma motor neurons, muscle spindle, Golgi tendon organ, stretch reflex arc
- NMJ transmission — ACh release cycle, safety factor, and how myasthenia gravis, Lambert-Eaton, and botulism each disrupt it
- Descending pathways — lateral system (voluntary distal limb) vs. medial system (postural/axial) and their clinical relevance
- Basal ganglia & cerebellum roles — movement selection vs. coordination/error correction
- Motor neuron disease patterns — ALS (UMN+LMN), PLS (pure UMN), PMA (pure LMN), SMA, Kennedy disease
- Localization — cortex vs. subcortical vs. brainstem vs. spinal cord vs. root vs. nerve vs. NMJ vs. muscle
Overview — The Motor Hierarchy
Levels of Motor Control
- Cerebral cortex (highest level) — voluntary movement planning and execution
- Primary motor cortex (M1, Brodmann area 4) → direct corticospinal output
- Premotor cortex (lateral area 6) → externally guided movement planning
- Supplementary motor area (medial area 6) → internally generated sequences
- Prefrontal areas → goal selection, decision to move
- Basal ganglia — movement selection, initiation, and suppression of unwanted movements; operate via cortex-BG-thalamus-cortex loops
- Cerebellum — coordination, timing, error correction; compares intended vs. actual movement and adjusts online
- Brainstem — posture, balance, locomotor pattern generation, muscle tone regulation (reticular formation, vestibular nuclei, red nucleus)
- Spinal cord — final common motor output; contains alpha motor neurons, interneuronal circuits, central pattern generators for locomotion
- Peripheral nerve → NMJ → muscle — signal transmission and force generation
Fundamental Concept: UMN vs. LMN
- Upper motor neuron (UMN) — any neuron whose cell body resides in the cortex or brainstem and whose axon descends to influence the lower motor neuron; lesion produces spasticity, hyperreflexia, Babinski
- Lower motor neuron (LMN) — the anterior horn cell, its axon through the ventral root and peripheral nerve, and the neuromuscular junction; lesion produces flaccidity, hyporeflexia, atrophy, fasciculations
- Clinical significance — distinguishing UMN from LMN is the first step in motor localization on every board question
Clinical Pearl — Spinal Shock
Acute UMN lesion (e.g., acute spinal cord injury) initially mimics LMN → flaccidity, areflexia, absent Babinski. Over days to weeks, UMN signs (spasticity, hyperreflexia, upgoing toes) emerge as spinal shock resolves. Do not be fooled on boards by a flaccid presentation in an acute cord lesion.
Upper Motor Neurons
Primary Motor Cortex (M1) — Brodmann Area 4
- Location: precentral gyrus
- Histology: agranular cortex; layer V contains Betz cells (giant pyramidal neurons, largest in the CNS) → contribute only ~3% of corticospinal fibers; majority arise from smaller layer V and layer III pyramidal neurons
- Motor homunculus (somatotopic map):
- Medial surface (paracentral lobule): foot, leg, perineum → supplied by ACA
- Lateral convexity (superior): trunk, arm
- Lateral convexity (middle): hand — disproportionately large representation (fine motor control)
- Lateral convexity (inferior): face, lips, tongue, larynx → supplied by MCA
- Function: execution of contralateral voluntary movements, especially fine, fractionated finger movements
Corticospinal Tract — Full Pathway
Origin
- ~30% from M1 (area 4)
- ~30% from premotor and SMA (area 6)
- ~40% from primary sensory cortex (areas 3, 1, 2) — modulates incoming sensory information
- Total: ~1 million fibers per side
Descending Course
- Corona radiata — fibers converge from cortex through centrum semiovale
- Posterior limb of internal capsule — tightly packed; somatotopy: face (anterior/genu), arm (middle), leg (posterior)
- Small lacunar infarct here → pure motor hemiparesis affecting face = arm = leg equally
- Cerebral peduncle (crus cerebri) — middle 3/5 of ventral midbrain; face medial, leg lateral
- Basis pontis — fibers disperse among pontine nuclei; corticobulbar fibers exit to cranial nerve motor nuclei
- Medullary pyramids — ventral medulla; distinct pyramidal elevations
- Pyramidal decussation — cervicomedullary junction:
- 85–90% of fibers cross → lateral corticospinal tract (dorsolateral funiculus) → controls distal limb muscles
- 10–15% remain ipsilateral → anterior corticospinal tract (anterior funiculus) → most eventually cross at segmental level via anterior white commissure; controls axial/proximal muscles; terminates by upper thoracic levels
- Lateral CST in spinal cord — fibers peel off medially at each segment to synapse on alpha motor neurons (directly) and interneurons (indirectly) in the ventral horn
Corticobulbar Tract
- Function: controls muscles of the face, jaw, pharynx, larynx, and tongue via motor cranial nerve nuclei
- Course: travels with corticospinal tract through internal capsule (genu and adjacent posterior limb) and cerebral peduncle; gives off fibers at brainstem levels
Pattern of Innervation
| Cranial Nerve | Cortical Innervation | Clinical Implication |
|---|---|---|
| CN V (mastication) | Bilateral | Unilateral cortical lesion → minimal jaw weakness |
| CN VII (upper face) — frontalis, orbicularis oculi | Bilateral | Forehead spared in UMN (central) facial palsy |
| CN VII (lower face) | Contralateral only | Lower face weak contralateral to cortical lesion |
| CN IX, X (palate, pharynx, larynx) | Bilateral | Unilateral lesion → mild dysarthria; bilateral lesion → pseudobulbar palsy |
| CN XI (SCM, trapezius) | Complex — SCM receives ipsilateral cortical input | Right cortical lesion → weakness turning head to the right (ipsilateral SCM) |
| CN XII (tongue) | Contralateral | UMN lesion → tongue deviates away from lesion; LMN lesion → tongue deviates toward lesion (with atrophy) |
Board Pearl — Central vs. Peripheral Facial Palsy
- Central (UMN): lower face weakness only; forehead spared (bilateral innervation); emotional facial movements may be preserved (different pathway)
- Peripheral (LMN — Bell palsy): entire hemiface including forehead; cannot close eye, wrinkle forehead
- Boards love this distinction — if forehead is spared, the lesion is above the facial nucleus (cortex, internal capsule, or upper pons)
UMN vs. LMN Signs
| Feature | Upper Motor Neuron (UMN) | Lower Motor Neuron (LMN) |
|---|---|---|
| Weakness pattern | Pyramidal distribution: extensors > flexors in arm; flexors > extensors in leg | Follows specific myotome, root, or nerve territory |
| Tone | Spasticity — velocity-dependent; "clasp-knife" phenomenon | Hypotonia / flaccidity |
| Deep tendon reflexes | Hyperreflexia; clonus (>3 beats = pathological) | Hyporeflexia or areflexia |
| Babinski sign | Upgoing (extensor plantar response) | Downgoing or mute (absent) |
| Atrophy | Minimal — disuse atrophy only, develops late | Prominent and early (weeks) — denervation atrophy |
| Fasciculations | Absent | Present — spontaneous motor unit firing from denervation |
| Distribution | Regional (hemiparesis, paraparesis) | Segmental (myotome, nerve) |
Clinical Pearl — Spasticity vs. Rigidity
- Spasticity (UMN) — velocity-dependent; "clasp-knife" (initial resistance gives way); affects antigravity muscles preferentially; caused by loss of corticospinal inhibition on spinal stretch reflex
- Rigidity (extrapyramidal / basal ganglia) — velocity-independent; "lead-pipe" or "cogwheel" (with superimposed tremor); affects flexors and extensors equally
- Boards test this distinction frequently — spasticity = pyramidal; rigidity = extrapyramidal
Board Pearl — UMN Signs in Upper Extremity
- Hoffman sign: flick the nail of the middle finger → involuntary flexion of thumb and index finger = UMN sign (the "Babinski of the arm")
- Pronator drift: arms outstretched, eyes closed → affected arm pronates and drifts downward = subtle UMN weakness
- Finger escape sign: hold fingers extended → little finger drifts into abduction = pyramidal tract dysfunction
Lower Motor Neurons
Anterior Horn Cells
- Location: ventral horn of spinal cord gray matter (Rexed lamina IX)
- Organization: motor neuron pools arranged somatotopically
- Medial motor column: axial and proximal muscles
- Lateral motor column: distal limb muscles (only present at cervical and lumbar enlargements)
- Within columns: extensors dorsal, flexors ventral
- "Final common pathway" — all motor commands (voluntary, reflex, postural) must converge on the alpha motor neuron to produce movement
Motor Unit Concept
- Definition: one alpha motor neuron + all the muscle fibers it innervates
- Innervation ratio:
- Small ratio (e.g., 1:5 in extraocular muscles) → fine, precise control
- Large ratio (e.g., 1:2000 in gastrocnemius) → gross, powerful movements
- Size principle (Henneman): motor units recruited from smallest (type I, slow-twitch) to largest (type II, fast-twitch) as force demand increases
- Force modulation: recruitment of additional motor units + rate coding (increased firing frequency)
Alpha vs. Gamma Motor Neurons
| Feature | Alpha Motor Neuron | Gamma Motor Neuron |
|---|---|---|
| Size | Large (70–120 µm axon diameter) | Small (2–8 µm) |
| Target | Extrafusal muscle fibers (force generation) | Intrafusal muscle fibers (within muscle spindle) |
| Function | Produces muscle contraction and movement | Adjusts sensitivity of muscle spindle; maintains spindle taut during contraction (alpha-gamma co-activation) |
| Clinical | Loss → weakness, atrophy, fasciculations | Loss → decreased spindle sensitivity → hypotonia, hyporeflexia |
Muscle Spindle Physiology
- Structure: encapsulated intrafusal fibers within the muscle belly; oriented parallel to extrafusal (contractile) fibers
- Intrafusal fiber types:
- Nuclear bag fibers — detect dynamic (velocity of) stretch; innervated by Ia afferents
- Nuclear chain fibers — detect static (magnitude of) stretch; innervated by type II afferents
- Ia afferents → enter spinal cord → monosynaptic excitation of alpha motor neurons to the same muscle → stretch (myotatic) reflex
- Example: knee jerk — tap patellar tendon → quadriceps stretch → Ia firing → L3-L4 alpha motor neuron → quadriceps contraction
- Reciprocal inhibition: Ia afferents also excite inhibitory interneurons → inhibit antagonist motor neurons (hamstrings relax when quadriceps contracts)
- Gamma motor neuron role: adjusts spindle length during voluntary contraction so the spindle remains sensitive; alpha-gamma co-activation ensures continuous proprioceptive feedback
Golgi Tendon Organs (GTOs)
- Structure: encapsulated receptors in muscle tendons; oriented in series with extrafusal fibers
- Innervation: Ib afferents (large, myelinated)
- Function: detect muscle tension (force), not length
- Ib afferents → inhibitory interneurons → inhibit alpha motor neurons of the same muscle (autogenic inhibition)
- Protective: prevents excessive force that could damage muscle/tendon
- Clinical correlation: "clasp-knife" phenomenon in spasticity may involve Ib-mediated inhibition — sudden release of resistance during passive stretch
Board Pearl — Stretch Reflex Arc
- Afferent limb: Ia afferents from muscle spindle
- Integration: monosynaptic in spinal cord (fastest reflex arc in the body)
- Efferent limb: alpha motor neuron to same muscle
- Modulation: descending UMN input normally inhibits the reflex arc → UMN lesion removes inhibition → hyperreflexia
- Reflex arc interruption at any point (dorsal root, anterior horn cell, ventral root, peripheral nerve, NMJ, or muscle) → hyporeflexia/areflexia
Neuromuscular Junction
NMJ Anatomy
- Presynaptic terminal (motor nerve terminal):
- Contains synaptic vesicles loaded with acetylcholine (ACh)
- Active zones — specialized release sites aligned with postsynaptic folds
- Voltage-gated calcium channels (P/Q-type) clustered at active zones — Ca2+ influx triggers vesicle fusion
- Synaptic cleft (~50 nm):
- Contains acetylcholinesterase (AChE) anchored to the basal lamina → rapidly degrades ACh
- Contains agrin (organizes postsynaptic receptors)
- Postsynaptic membrane (motor end plate):
- Junctional folds increase surface area
- Nicotinic ACh receptors (AChRs) concentrated at the crests of folds (~10,000/µm2)
- Voltage-gated Na+ channels at depths of folds → amplify end-plate potential into muscle action potential
- Receptor clustering maintained by rapsyn and MuSK (muscle-specific kinase)
ACh Synthesis, Release & Degradation
- Synthesis: choline + acetyl-CoA → ACh via choline acetyltransferase (ChAT) in the nerve terminal
- Packaging: ACh loaded into vesicles by vesicular ACh transporter (VAChT); each vesicle contains ~10,000 ACh molecules (one quantum)
- Release: nerve action potential → Ca2+ entry through P/Q-type channels → SNARE complex-mediated vesicle fusion → exocytosis of ~200 quanta per impulse
- Receptor binding: ACh binds nicotinic AChR (ligand-gated ion channel) → Na+/K+ flux → end-plate potential (EPP)
- Degradation: AChE rapidly hydrolyzes ACh to choline + acetate; choline recycled into nerve terminal via high-affinity choline transporter
Safety Factor Concept
- Definition: the EPP is normally 3–4 times the threshold needed to trigger a muscle action potential
- This "safety margin" ensures reliable 1:1 neuromuscular transmission even with physiological variation
- Reduced safety factor → transmission failure → fatigable weakness
- Myasthenia gravis: fewer AChRs → smaller EPP → reduced safety factor → failure with repetitive use (fatigue)
- Lambert-Eaton: fewer Ca2+ channels → less ACh release → small EPP initially → facilitation with repetitive use (post-exercise potentiation)
NMJ Disorders — Overview
| Feature | Myasthenia Gravis | Lambert-Eaton (LEMS) | Botulism |
|---|---|---|---|
| Target | Postsynaptic AChR (or MuSK) | Presynaptic P/Q-type Ca2+ channels | Presynaptic SNARE proteins (blocks vesicle fusion) |
| Mechanism | Antibody-mediated AChR destruction/blockade | Antibody-mediated reduction of Ca2+ influx → decreased ACh release | Botulinum toxin cleaves SNARE → prevents ACh exocytosis |
| Weakness pattern | Ocular → bulbar → proximal limbs; fatigable | Proximal limbs (legs > arms); ocular sparing common | Descending: cranial nerves first → limbs → respiratory |
| Reflexes | Normal | Hyporeflexia (improve after exercise) | Hyporeflexia |
| Autonomic | No | Yes (dry mouth, constipation, erectile dysfunction) | Yes (dilated pupils, dry mouth, constipation) |
| RNS pattern | Decremental response at low-frequency (2–3 Hz) | Low CMAP; incremental response (>100%) at high-frequency or post-exercise | Low CMAP; incremental at high-frequency (similar to LEMS) |
| Association | Thymoma (10–15%); thymic hyperplasia | Small cell lung cancer (~60%); paraneoplastic | Canned food (toxin); wound; infant (honey/spores) |
Board Pearl — NMJ Localization
- NMJ disorders produce weakness WITHOUT sensory loss, WITHOUT reflex changes (MG), and WITHOUT UMN signs
- Key distinguisher from myopathy: fatigability (weakness worsens with repetitive use, improves with rest)
- Ice test: place ice on ptotic eyelid for 2 minutes → improvement suggests MG (cold inhibits AChE, prolonging ACh action)
- MuSK-MG: bulbar-predominant, may have tongue/facial atrophy (mimics LMN), poor response to pyridostigmine, AChR-Ab negative
Descending Motor Pathways
Lateral System — Voluntary Distal Limb Control
- Lateral corticospinal tract
- Origin: motor cortex → crosses at pyramidal decussation → lateral funiculus
- Function: fine, fractionated distal limb movements (especially hand and fingers)
- Lesion: contralateral UMN weakness (pyramidal distribution)
- Rubrospinal tract
- Origin: red nucleus (magnocellular part) → crosses immediately in ventral tegmental decussation (of Forel) → descends near lateral CST
- Function: facilitates flexor tone in upper extremity; rudimentary in humans
- Clinical: contributes to decorticate posture (flexion of arms) when corticospinal tract is damaged above red nucleus level
Medial System — Posture, Balance, and Axial Control
- Lateral vestibulospinal tract
- Origin: lateral vestibular nucleus (Deiters') → descends ipsilaterally
- Function: facilitates ipsilateral extensors → maintains upright posture against gravity
- Clinical: key driver of decerebrate rigidity (extension of all extremities)
- Medial vestibulospinal tract
- Origin: medial vestibular nucleus → descends bilaterally via MLF → cervical cord only
- Function: head and neck stabilization; coordinates with eye movements (VOR)
- Pontine (medial) reticulospinal tract
- Origin: pontine reticular formation → descends ipsilaterally in anterior funiculus
- Function: facilitates extensors, inhibits flexors → anti-gravity posture
- Medullary (lateral) reticulospinal tract
- Origin: medullary reticular formation → descends bilaterally in lateral funiculus
- Function: facilitates flexors, inhibits extensors → opposes pontine reticulospinal
- Clinical: balance of pontine vs. medullary reticulospinal determines resting tone; corticospinal input normally enhances medullary (flexor) system
- Tectospinal tract
- Origin: superior colliculus → crosses in dorsal tegmental decussation → cervical cord only
- Function: reflexive head/neck turning toward visual and auditory stimuli
Summary Table — Descending Pathways
| Pathway | System | Origin | Laterality | Primary Function | Clinical Relevance |
|---|---|---|---|---|---|
| Lateral corticospinal | Lateral | Cortex | Contralateral (crosses at medullary pyramids) | Voluntary distal limb control | UMN weakness (pyramidal pattern) |
| Rubrospinal | Lateral | Red nucleus | Contralateral (ventral tegmental decussation) | Upper limb flexor facilitation | Decorticate posture |
| Lateral vestibulospinal | Medial | Lateral vestibular nucleus | Ipsilateral | Extensor facilitation; antigravity | Decerebrate posture |
| Medial vestibulospinal | Medial | Medial vestibular nucleus | Bilateral | Head/neck stabilization | VOR integration |
| Pontine reticulospinal | Medial | Pontine reticular formation | Ipsilateral | Extensor facilitation | Contributes to decerebrate rigidity |
| Medullary reticulospinal | Medial | Medullary reticular formation | Bilateral | Flexor facilitation | Opposes pontine; balance = normal tone |
| Tectospinal | Medial | Superior colliculus | Contralateral | Orienting head/neck to stimuli | Cervical cord only; minimal clinical significance |
| Anterior corticospinal | Medial | Cortex | Ipsilateral (crosses at segmental level) | Axial/proximal muscle control | Bilateral innervation; trunk spared in unilateral lesions |
Clinical Pearl — Decerebrate vs. Decorticate Posturing
- Decorticate (flexor posturing): lesion above red nucleus (cortex/internal capsule) → arms flexed, legs extended
- Mechanism: loss of corticospinal input; intact rubrospinal → upper limb flexion
- Decerebrate (extensor posturing): lesion below red nucleus (midbrain/pons) → all extremities extended, arms pronated
- Mechanism: loss of both corticospinal AND rubrospinal; unopposed vestibulospinal/pontine reticulospinal → extension
- Decerebrate carries worse prognosis than decorticate
- Mnemonic: de-COR-ticate = CORtex damage = flexion toward CORe
Motor Control Centers
Basal Ganglia — Movement Selection and Initiation
- Role: does NOT generate movement directly; modulates cortical motor output by facilitating desired movements and suppressing competing/unwanted movements
- Circuit: cortex → striatum (caudate + putamen) → GPi/SNr → thalamus (VA/VL) → cortex
- Direct pathway: cortex → striatum → GPi (inhibition) → releases thalamus from inhibition → facilitates movement
- Indirect pathway: cortex → striatum → GPe → STN → GPi (excitation) → inhibits thalamus → suppresses movement
- Dopamine (from SNc): excites direct pathway (D1 receptors) and inhibits indirect pathway (D2 receptors) → net effect: facilitates movement
- Dopamine loss (Parkinson disease): underactivity of direct + overactivity of indirect → excessive GPi inhibition of thalamus → bradykinesia, rigidity
- Excess dopamine or striatal damage (Huntington): underactivity of indirect pathway → insufficient movement suppression → chorea, hyperkinesia
Cerebellum — Coordination and Error Correction
- Role: compares intended movement (from cortex) with actual movement (from sensory feedback) and generates correction signals
- Functional zones:
- Vestibulocerebellum (flocculonodular lobe): balance, VOR; lesion → truncal ataxia, nystagmus
- Spinocerebellum (vermis + intermediate zone): posture, gait, proximal/axial coordination; lesion → gait ataxia, truncal instability
- Cerebrocerebellum (lateral hemispheres): motor planning, timing, limb coordination; lesion → ipsilateral limb dysmetria, intention tremor, dysdiadochokinesia
- Key principle: cerebellar lesions produce ipsilateral signs (double-cross: cerebellum → contralateral red nucleus/thalamus → contralateral cortex → contralateral body = ipsilateral to cerebellum)
- Cerebellar signs (mnemonic DANISH): Dysdiadochokinesia, Ataxia, Nystagmus, Intention tremor, Scanning speech/Slurred speech, Hypotonia
Brainstem Motor Centers
- Reticular formation: regulates muscle tone through reticulospinal tracts (pontine = excitatory to extensors; medullary = excitatory to flexors)
- Vestibular nuclei: maintain posture and balance; integrate vestibular, visual, and proprioceptive inputs
- Red nucleus: relay between cerebellum and cortex; rubrospinal tract facilitates upper limb flexors
- Mesencephalic locomotor region (MLR): contains pedunculopontine nucleus; involved in initiating and maintaining locomotion; damage → gait freezing (relevant in Parkinson disease)
- Superior colliculus: orienting head/neck/eyes toward stimuli via tectospinal tract
Board Pearl — Basal Ganglia vs. Cerebellum on Boards
- Basal ganglia lesion: movement disorders (tremor at rest, rigidity, bradykinesia, chorea, dystonia, athetosis) — no ataxia
- Cerebellar lesion: coordination deficits (ataxia, dysmetria, intention tremor, hypotonia, nystagmus) — no rigidity or resting tremor
- Tremor distinction: BG = resting tremor (4–6 Hz, improves with action); cerebellar = intention/action tremor (worsens at target)
- Tone distinction: BG = rigidity (lead-pipe/cogwheel); cerebellar = hypotonia; UMN = spasticity
Motor Neuron Disease Patterns
Amyotrophic Lateral Sclerosis (ALS)
- Pathology: degeneration of both UMN and LMN simultaneously
- UMN signs: spasticity, hyperreflexia, Babinski, pseudobulbar affect
- LMN signs: weakness, atrophy, fasciculations (often tongue fasciculations)
- Spared: extraocular movements, sphincter function, sensation (absence of sensory findings is a diagnostic clue)
- Split hand sign: preferential wasting of thenar eminence and first dorsal interosseous relative to hypothenar → highly characteristic of ALS
- El Escorial criteria: UMN + LMN signs in 2+ regions with progressive spread; absence of alternative diagnosis
- EMG: active denervation (fibrillations, positive sharp waves) + chronic reinnervation (large polyphasic MUPs) in multiple myotomes
- Genetics: ~10% familial; most common mutation = C9orf72 hexanucleotide repeat expansion (also associated with FTD); SOD1 is classic
Primary Lateral Sclerosis (PLS)
- Pure UMN disease: progressive spasticity, hyperreflexia, Babinski
- No LMN signs: no atrophy, no fasciculations, normal EMG (no denervation)
- Diagnosis: requires ≥4 years without LMN signs (if LMN signs appear earlier, reclassify as UMN-dominant ALS)
- Prognosis: significantly better than ALS; slower progression; median survival >10 years
- Pseudobulbar affect common (bilateral UMN involvement)
Progressive Muscular Atrophy (PMA)
- Pure LMN disease: progressive weakness, atrophy, fasciculations
- No UMN signs: reflexes reduced or absent; no spasticity or Babinski
- Prognosis: better than classic ALS but ~30% eventually develop UMN signs → reclassified as ALS
- Must exclude multifocal motor neuropathy (treatable mimic) with anti-GM1 antibodies and conduction block on NCS
Spinal Muscular Atrophy (SMA)
- Genetics: autosomal recessive; homozygous deletion/mutation of SMN1 gene (5q13)
- Pathology: degeneration of anterior horn cells → pure LMN disease
- SMN2 copy number modifies severity (more copies → milder phenotype)
- Treatment: nusinersen (antisense oligonucleotide, enhances SMN2 splicing), onasemnogene abeparvovec (gene therapy, delivers SMN1), risdiplam (oral SMN2 splicing modifier)
| SMA Type | Onset | Motor Milestone | Key Features | Natural Survival |
|---|---|---|---|---|
| Type 1 (Werdnig-Hoffmann) | 0–6 months | Never sit | Severe hypotonia, "frog-leg" posture, tongue fasciculations, areflexia, respiratory failure | <2 years (without treatment) |
| Type 2 | 6–18 months | Sit but never walk | Proximal weakness, hand tremor, scoliosis | >2 years; variable |
| Type 3 (Kugelberg-Welander) | >18 months | Walk then lose ambulation | Proximal weakness (Gowers sign), may mimic muscular dystrophy | Normal lifespan |
| Type 4 | Adulthood | Walk independently | Mild proximal weakness; slowly progressive | Normal lifespan |
Kennedy Disease (SBMA)
- Genetics: X-linked recessive; CAG trinucleotide repeat expansion in androgen receptor gene
- Epidemiology: males only (females are carriers); onset 3rd–5th decade
- LMN pattern: proximal limb and bulbar weakness, fasciculations (especially perioral/chin), tongue atrophy
- Distinguishing features from ALS:
- No UMN signs (pure LMN)
- Sensory neuropathy (reduced vibration sense, low-amplitude SNAPs)
- Endocrine features: gynecomastia, testicular atrophy, infertility, diabetes
- Slower progression than ALS; lifespan only mildly reduced
Comparison Table — Motor Neuron Diseases
| Disease | UMN Signs | LMN Signs | Sensory | Genetics | Prognosis |
|---|---|---|---|---|---|
| ALS | Yes | Yes | Spared | ~10% familial (C9orf72, SOD1) | Median 3–5 years |
| PLS | Yes | No | Spared | Usually sporadic | Median >10 years |
| PMA | No | Yes | Spared | Usually sporadic | Better than ALS; variable |
| SMA | No | Yes | Spared | AR; SMN1 deletion (5q13) | Type-dependent |
| Kennedy (SBMA) | No | Yes | Affected (sensory neuropathy) | X-linked; CAG repeat in AR gene | Near-normal lifespan |
Board Pearl — ALS Mimics to Exclude
- Multifocal motor neuropathy (MMN): pure LMN, asymmetric, distal UE predominant; anti-GM1 antibodies; conduction block on NCS; treatable with IVIg
- Cervical myelopathy with radiculopathy: may produce UMN + LMN; MRI spine is essential
- Kennedy disease: LMN + sensory + endocrine features; no UMN signs
- Inclusion body myositis: weakness may mimic ALS; check CK, EMG (myopathic), and biopsy
- Hirayama disease (monomelic amyotrophy): young male, unilateral hand atrophy, non-progressive; flexion MRI shows forward displacement of posterior dura
Clinical Localization of Motor Lesions
Localization Framework
- For every motor complaint, ask: "Where in the neuroaxis is the lesion?"
- Use the combination of weakness distribution, UMN vs. LMN signs, associated features (sensory, cranial nerve, autonomic), and temporal profile to localize
Master Localization Table
| Level | Weakness Pattern | Tone / Reflexes | Atrophy / Fasciculations | Key Distinguishing Features |
|---|---|---|---|---|
| Motor cortex | Contralateral; face/arm OR leg depending on vascular territory (MCA vs. ACA) | UMN: spasticity, hyperreflexia, Babinski | Minimal | Associated cortical signs: aphasia, neglect, seizures, visual field cuts; face spares forehead (central VII) |
| Subcortical (internal capsule) | Contralateral face = arm = leg (pure motor hemiparesis) | UMN | Minimal | No cortical signs (no aphasia, neglect, or field cut); lacunar infarct syndrome |
| Brainstem | Contralateral hemiparesis + ipsilateral cranial nerve palsy (crossed syndrome) | UMN below lesion | LMN at cranial nerve level | Weber (CN III + hemiparesis), Millard-Gubler (CN VI/VII + hemiparesis), medial medullary (CN XII + hemiparesis) |
| Spinal cord | Below the level: UMN (paraparesis or quadriparesis); at the level: LMN in that myotome | UMN below; LMN at level | LMN atrophy at level only | Sensory level; bladder/bowel dysfunction; Brown-Séquard, central cord, anterior cord syndromes |
| Nerve root | Follows myotome; usually one root distribution | LMN: hypotonia, hyporeflexia (if reflex arc involved) | Possible in myotomal distribution | Dermatomal sensory loss; radicular pain; reduced specific DTR (e.g., C6 → absent biceps jerk) |
| Peripheral nerve | Follows named nerve territory; may be mononeuropathy or polyneuropathy | LMN | Yes, in nerve distribution | Sensory loss in nerve territory; polyneuropathy = stocking-glove; mononeuropathy = specific nerve map |
| NMJ | Fatigable weakness; fluctuating; no fixed pattern initially | Normal tone; reflexes usually preserved (MG) or reduced (LEMS) | No atrophy (early); no fasciculations | No sensory loss; fatigability is hallmark; ptosis/diplopia in MG; proximal > distal in LEMS; autonomic features in LEMS/botulism |
| Muscle | Proximal > distal (hip flexors, shoulder abductors); symmetric; no fatigability | Hypotonia; reflexes reduced late | Atrophy (late); no fasciculations | Elevated CK; no sensory loss; myopathic EMG (short, small, polyphasic MUPs); may have myotonia, rash (dermatomyositis) |
Cortical vs. Subcortical Localization
- Cortical clues: seizures, aphasia, neglect, visual field deficits, cortical sensory loss (agraphesthesia, astereognosis), proportional weakness (face/arm > leg in MCA; leg > arm in ACA)
- Subcortical (internal capsule/corona radiata) clues: equal face/arm/leg involvement, NO cortical signs, pure motor or pure sensory syndromes, lacunar pattern
Distinguishing NMJ from Myopathy
| Feature | NMJ Disorder | Myopathy |
|---|---|---|
| Fatigability | Prominent (worse with use, better with rest) | Absent (weakness is constant) |
| Fluctuation | Diurnal variation; day-to-day variability | Stable or slowly progressive |
| Ocular involvement | Very common (ptosis, diplopia) in MG | Rare (except oculopharyngeal muscular dystrophy, mitochondrial myopathy) |
| CK | Normal | Usually elevated |
| EMG | Decremental response on RNS; unstable MUPs with jitter on single-fiber EMG | Myopathic MUPs (short duration, small amplitude, polyphasic, early recruitment) |
Clinical Pearl — Motor Localization Strategy for Boards
- Step 1 — UMN or LMN? Check tone, reflexes, Babinski, atrophy, fasciculations
- Step 2 — Distribution?
- Hemiparesis → cortex, subcortical, or brainstem
- Paraparesis → bilateral cortex (parasagittal), spinal cord, or bilateral peripheral (GBS)
- Quadriparesis → cervical cord, brainstem, or diffuse LMN/NMJ/muscle
- Single limb → root, plexus, nerve, or cord (consider contralateral brain)
- Step 3 — Associated features?
- Cortical signs (aphasia, neglect) → cortex
- Crossed cranial nerve + hemiparesis → brainstem
- Sensory level + bladder → spinal cord
- Dermatomal sensory + radicular pain → root
- No sensory loss + fatigability → NMJ
- No sensory loss + proximal + elevated CK → muscle
- Step 4 — Time course? Acute (vascular, traumatic), subacute (inflammatory, infectious), chronic (degenerative, genetic)
Board Pearl — Acute Flaccid Paralysis Differential
- Spinal cord: acute transverse myelitis, spinal cord infarction → flaccid (spinal shock phase) with sensory level and bladder involvement
- Anterior horn: poliomyelitis, West Nile, enterovirus (acute flaccid myelitis) → asymmetric LMN weakness, no sensory loss
- Nerve roots / peripheral nerve: Guillain-Barré syndrome → ascending symmetric weakness, areflexia, albuminocytologic dissociation in CSF
- NMJ: botulism → descending paralysis, autonomic features, no sensory loss
- Muscle: critical illness myopathy, rhabdomyolysis → elevated CK, myopathic EMG
- Key distinguisher: presence or absence of sensory findings narrows the differential rapidly
References
- Blumenfeld H. Neuroanatomy through Clinical Cases. 3rd ed. Sinauer Associates; 2021.
- Brazis PW, Masdeu JC, Biller J. Localization in Clinical Neurology. 8th ed. Wolters Kluwer; 2022.
- Kandel ER, Koester JD, Mack SH, Siegelbaum SA. Principles of Neural Science. 6th ed. McGraw-Hill; 2021.
- Ropper AH, Samuels MA, Klein JP, Prasad S. Adams and Victor's Principles of Neurology. 12th ed. McGraw-Hill; 2023.
- Aminoff MJ, Greenberg DA, Simon RP. Clinical Neurology. 11th ed. McGraw-Hill; 2021.
- Preston DC, Shapiro BE. Electromyography and Neuromuscular Disorders. 4th ed. Elsevier; 2021.
- Continuum (Minneap Minn). Motor Neuron Disease. American Academy of Neurology; 2023.